These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23179830)

  • 1. Simultaneous cloning and selection of hybridomas and transfected cell lines in semisolid media.
    Wognum B; Lee T
    Methods Mol Biol; 2013; 946():133-49. PubMed ID: 23179830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and subcloning of high producer transfectomas using semisolid media and automated colony picker.
    Dharshanan S; Hung CS
    Methods Mol Biol; 2014; 1131():105-12. PubMed ID: 24515462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
    Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
    Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeder cells from different sources and conditioned media for recloning of human--mouse and mouse--mouse hybridomas.
    Hlinak A; Jahn S; Grunow R; Heider G; von Baehr R
    Folia Biol (Praha); 1988; 34(2):105-17. PubMed ID: 3396727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
    Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
    Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-free transfection of CHO host cells with an IgG-fusion protein: selection and characterization of stable high producers and comparison to conventionally transfected clones.
    Lattenmayer C; Loeschel M; Schriebl K; Steinfellner W; Sterovsky T; Trummer E; Vorauer-Uhl K; Müller D; Katinger H; Kunert R
    Biotechnol Bioeng; 2007 Apr; 96(6):1118-26. PubMed ID: 17004273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybridoma generation by in vitro immunization of murine splenocytes with cytosolic proteins of Chinese hamster ovary (CHO) mitotic cells.
    Ravi M; Sundar SS; Kumar KK; Parvathi D; Paul SF
    Hybridoma (Larchmt); 2007 Oct; 26(5):311-5. PubMed ID: 17979547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of postfusion cell density on establishment of hybridomas.
    Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
    Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
    Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
    Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated in situ measurement of cell-specific antibody secretion and laser-mediated purification for rapid cloning of highly-secreting producers.
    Hanania EG; Fieck A; Stevens J; Bodzin LJ; Palsson BØ; Koller MR
    Biotechnol Bioeng; 2005 Sep; 91(7):872-6. PubMed ID: 15937942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Defined media for hybridoma culture: do they really replace serum and why are they attractive?].
    Boschetti E; Pouradier Duteil X; Sene C
    Ann Pharm Fr; 1991; 49(4):198-208. PubMed ID: 1781602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas.
    Kawamoto T; Sato JD; Le A; McClure DB; Sato GH
    Anal Biochem; 1983 Apr; 130(2):445-53. PubMed ID: 6869833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescein-specific hybridomas derived from primary mice exhibit more stringent growth requirements than do hybrids from pre-immune animals.
    Skeath JB; Dalesandro MR; Ferguson MA; Kinnel GC; Owen JA
    J Immunol Methods; 1990 Oct; 133(1):39-45. PubMed ID: 2212690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of hybridoma formation, clonability and cell proliferation in a nanoparticle-doped aqueous environment.
    Gavrilov-Yusim N; Hahiashvili E; Tashker M; Yavelsky V; Karnieli O; Lobel L
    BMC Biotechnol; 2008 Jan; 8():3. PubMed ID: 18194567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of hybridomas generated by spleen cells of IL-4- and IL-13-knockout mice.
    Shichkin VP; Spivak NY
    Hybridoma (Larchmt); 2005 Dec; 24(6):291-7. PubMed ID: 16332195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of mammalian cell autotrophs able to grow indefinitely in protein-free chemically defined medium.
    Hillova J; Hill M; Nakamura T; Mariage-Samson R
    Anticancer Res; 1990; 10(1):181-4. PubMed ID: 2334124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridoma cell growth and monoclonal antibody yield in serum-free media.
    Simonson L; Morton H; Reedy E
    Cytobios; 1994; 77(310):159-65. PubMed ID: 8020250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies and Selection of Monoclonal Antibodies.
    Hanack K; Messerschmidt K; Listek M
    Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.
    Mao SJ; France DS
    J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.